Skip to main content
. 2015 Oct 14;10(10):e0140450. doi: 10.1371/journal.pone.0140450

Table 2. Rate ratio (RR) of recurrent subdural haematoma (SDH) within the first year and after the first year of follow-up, according to concomitant medical diseases and other potential predictors in Denmark 1996–2011.

Potential predictors for recurrent SDH <1 year ≥1 year P-value +
Events Adjusted RR ** (95% CI*) Events Adjusted RR ** (95% CI*)
Age (years)
 20–49 211 1 (Ref.) 44 1 (Ref.) 0.09
 50–69 452 1.13 (0.96–1.34) 59 0.95 (0.64–1.41)
 70- 731 1.47 (1.24–1.74) 58 1.06 (0.71–1.58)
Gender
 Males 1042 1.63 (1.44–1.84) 115 1.43 (1.03–2.04) 0.50
 Females 352 1 (Ref.) 46 1 (Ref.)
Alcohol addiction
 Yes 275 1.05 (0.91–1.22) 61 2.68 (1.93–3.68) < .0001
 No 1119 1 (Ref.) 100 1 (Ref.)
Chronic liver disease
 Yes 63 1.16 (0.88–1.50) 12 2.71 (1.41–4.70) 0.02
 No 1331 1 (Ref.) 149 1 (Ref.)
Coagulopathy
 Yes 14 1.17 (0.66–1.91) 1 1.31 (0.07–5.83) 0.92
 No 1380 1 (Ref.) 160 1 (Ref.)
Surgical treatment
 Yes 856 1.77 (1.58–1.98) 101 1.61 (1.17–2.24) 0.59
 No 538 1 (Ref.) 60 1 (Ref.)
Antihypertensive treatment
 Yes 440 0.92 (0.81–1.04) 40 1.13 (0.78–1.60) 0.29
 No 954 1 (Ref.) 121 1 (Ref.)
Renal insufficiency
 Yes 34 1.18 (0.82–1.64) 2 1.23 (0.20–3.87) 0.95
 No 1360 1 (Ref.) 159 1 (Ref.)
Diabetes mellitus
 Yes 90 1.44 (1.14–1.79) 3 0.76 (0.19–2.00) 0.23
 No 1304 1 (Ref.) 158 1 (Ref.)
Previous cerebral ischemic infarction
 Yes 103 0.99 (0.80–1.21) 10 1.15 (0.57–2.07) 0.67
 No 1291 1 (Ref.) 151 1 (Ref.)
Statins
 Yes 167 1.01 (0.84–1.21) 5 0.50 (0.18–1.10) 0.09
 No 1227 1 (Ref.) 156 1 (Ref.)
Trauma diagnosis
 Yes 832 1.12 (1.00–1.25) 95 1.36 (0.99–1.87) 0.25
 No 562 1 (Ref.) 66 1 (Ref.)
PDMD ††
 Yes 26 0.94 (0.62–1.37) 4 4.06 (1.25–9.64) 0.02
 No 1368 1 (Ref.) 157 1 (Ref.)

* 95% Confidence interval

** Rate ratios adjusted for calendar period, time since admittance for first SDH, length of hospital stay for the primary bleeding, and potential predictors for recurrent SDH listed in Table 1.

+ P-value: Comparison of the RR’s within and after the first year, following the primary SDH.

Homogeneity test

Trauma diagnosis less than 2 years before the primary SDH

†† PDMD: Pre-packaged Daily Medication Doses.